Effect of cannabis use on PTSD treatment outcomes in veterans.

Introduction: Researchers have found anandamide (an endocannabinoid) and cannabinoid type 1 receptor activation encourages extinction of aversive memories. Some theorize cannabinoids such as those in cannabis may provide a new treatment approach for PTSD, while others suggest it may worsen symptomology. The objective of the current study was to determine if cannabis use impacts the success of evidence-based intensive outpatient PTSD treatment in a veteran population.

Propranolol for mirtazapine-induced akathisia: Single case report.

Despite psychomotor restlessness and akathisia being an occasionally reported side effect of antidepressants as a class, and mirtazapine specifically, there is no general consensus on the best treatment approach. Propranolol may prove to be an effective treatment approach in patients who are not candidates for alternative therapies.

Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: A retrospective review.

Introduction: Quetiapine fumarate is an atypical antipsychotic approved for the treatment of schizophrenia, major depressive disorder, and bipolar disorder. Due to the sedative effects observed at low doses, prescribers use quetiapine to aid patients with sleep disturbances. Current evidence has established that quetiapine can cause negative changes in metabolic parameters, but it is unknown if these consequences also occur at low doses.